- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech High Growth Potential Companies
Australian Pharmaceuticals & Biotech High Growth Potential Companies
Results
15
Companies with a Future performance score of at least 3, ordered by Future performance score.
15 companies
Botanix Pharmaceuticals
Market Cap: AU$236.5m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.12
7D
0%
1Y
-66.7%
EZZ Life Science Holdings
Market Cap: AU$80.2m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$1.70
7D
-29.2%
1Y
-32.8%
Mesoblast
Market Cap: AU$3.5b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.71
7D
17.3%
1Y
53.1%
Clinuvel Pharmaceuticals
Market Cap: AU$597.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$11.90
7D
10.7%
1Y
-9.5%
Immutep
Market Cap: AU$448.9m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.30
7D
17.3%
1Y
-6.2%
PYC Therapeutics
Market Cap: AU$933.2m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.60
7D
15.9%
1Y
-13.5%
Telix Pharmaceuticals
Market Cap: AU$5.2b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$15.22
7D
10.4%
1Y
-38.5%
Medical Developments International
Market Cap: AU$59.1m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.53
7D
2.9%
1Y
25.0%
Aroa Biosurgery
Market Cap: AU$227.7m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.66
7D
-1.5%
1Y
-6.4%
Trajan Group Holdings
Market Cap: AU$102.2m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.67
7D
3.1%
1Y
-33.0%
Paradigm Biopharmaceuticals
Market Cap: AU$165.0m
Engages in the research and development of therapeutic products for human use in Australia.
PAR
AU$0.39
7D
26.2%
1Y
-25.2%
Alterity Therapeutics
Market Cap: AU$108.8m
Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.
ATH
AU$0.01
7D
11.1%
1Y
150.0%
Cynata Therapeutics
Market Cap: AU$67.7m
Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.
CYP
AU$0.28
7D
11.8%
1Y
32.6%
Clarity Pharmaceuticals
Market Cap: AU$1.3b
A clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States.
CU6
AU$3.61
7D
0.8%
1Y
-43.7%
Island Pharmaceuticals
Market Cap: AU$133.7m
A drug repurposing company, focuses on the development of antiviral therapeutics for antiviral therapeutics in Australia and the United States of America.
ILA
AU$0.53
7D
1.0%
1Y
169.2%